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Gordon Parker1,2*, Amelia Paterson1,2, Kathryn Fletcher1,2, Georgia McClure1,2 and Michael Berk3,4,5Abstract
Background: The Experiences of Therapy Questionnaire (ETQ) is a reliable measure of adverse effects associated
with psychotherapy. The measure has not been subject to validity analyses. This study sought to examine the
validity of the ETQ by comparison against a measure of therapist satisfaction.
Methods: Participants were recruited from the Black Dog Institute’s website and completed all measures online, at
two time points (two weeks apart). Correlational analyses compared scale scores on the ETQ with related constructs
of the Therapist Satisfaction Scale (TSS). To exclude any impact of current depression on ratings, we examined
correlations between salient ETQ and TSS scales after controlling for depression severity.
Results: Forty-six participants completed all the measures at both time points. Hypothesised associations between
the ETQ and TSS scales were supported, irrespective of current depression severity.
Conclusions: The validity of the ETQ is supported; however limitations of the study are noted, including
generalizability due to sample characteristics.
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We previously proposed [1] that psychotherapy can, as
for any other active therapy, risk possible ‘side-effects’.
Such a proposition risks being viewed as incongruous
for a ‘talking therapy’ and elicited some engagement with
correspondents when we originally published our prop-
osition [2-4]. Some were positive comments, in stating
that ‘all clinicians need to acknowledge that any treat-
ment that has the capacity to greatly help the patient
can also in equal measure have the potential to cause
harm’ [3] or in basically agreeing with the premise [4].
However, correspondents also urged prudence when
distinguishing between negative effects of therapy and
negative effects of the therapist [3], and cautioned about
framing an event such as sexual exploitation of a patient
as a ‘side-effect’ instead of a gross violation of conduct
[2,3]. Such views encourage consideration of what is
really meant by the term ‘side-effect’. For drug therapies,
the term is normally used for any adverse event that is* Correspondence: g.parker@unsw.edu.au
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unless otherwise stated.considered to be a negative consequence of the medica-
tion. In psychotherapy, side-effects have previously been
described to include ‘adverse treatment reactions’ that
are defined as unwanted events caused by treatment
which has been applied according to the rules [5]
thereby distinguishing these side-effects from therapist
misconduct. We suggest, in accordance with the above
definition, that reasons for terminating drug therapy or
psychotherapy due to negative experiences (e.g. feeling
judged by a therapist) can both equally be termed side-
effects. We understand that this may be considered a con-
troversial definition but note that the term ‘side-effect’ has
been used to describe a range of negative outcomes of
psychotherapy from deterioration in functioning [6],
lowered expectations of therapeutic benefit [6] to harm-
ful therapy techniques [7]. Indeed, it has been argued
that training therapists to evaluate side-effects of their
therapy is crucial and standardized instruments to
evaluate such effects are recommended [5,6]. In addition
to this, it has been suggested that the best avenue of
obtaining information on both the positive and negative
effects of psychotherapy is via client feedback [7,8].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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broadly - reflecting an adverse outcome as a conse-
quence of therapy. Feedback from our initial paper was
taken into consideration when we developed (Parker
et al., 2013) a self-report measure to assess negative
outcomes in psychotherapy - the Experiences of Therapy
Questionnaire (ETQ) – and where we also established the
reliability of the ETQ [9].
Content validity was established during the develop-
ment of the ETQ. First, studies assessing psychothera-
peutic ingredients that impact on psychotherapy were
reviewed. Items derived from this review process largely
captured eight domains including client efficacy, the
therapeutic relationship, impact of therapy, rational/
treatment ‘fit’, treatment as restorative, therapist factors
and the therapeutic setting. The items were reviewed by
three clinicians (two psychiatrists and a psychologist) to
ensure key aspects were represented. This process yielded
103 items that were then refined to the 63 contained in
the final version of the ETQ [9]. The reliability of the ETQ
has been reported elsewhere [9].
A factorial analysis favoured a five-factor solution. Factor
one (‘Negative Therapist’), captures a construct where the
therapist lacks empathy or respect, is intrusive in manner,
or judgemental. Factor two (‘Preoccupying Therapy’) cap-
tures therapy which becomes consuming or overwhelming
to the patient. Low scores on Factor three (‘Beneficial
Therapy’) capture therapy being viewed as unsuccessful in
addressing reasons bringing the individual to seek treat-
ment. Factor four (‘Idealisation of Therapist’) applies when
the patient becomes dependent on or even physically
attracted to the therapist. Factor five (‘Passive Therapist’)
captures a therapy style of doing little or using techniques
not believed in by the patient.
As the construct validity of the ETQ has not yet been
considered, we undertook the current investigation.
We sought to establish the construct validity of the
ETQ by examining levels of agreement between the
ETQ and a conceptually related instrument assessing




Participants were recruited via The Black Dog Institute
Website. The Black Dog Institute is a Sydney-based
organisation that provides clinical intervention and
management, and undertakes research, professional
training and public education dedicated to improving
the lives of individuals affected by mood disorders.
The Institute website offers information, online tools
and resources for both mental health professionals and
the community. In 2012, 846,585 unique viewers accessed
the Black Dog website. The website contains links tocurrent research projects, and this was the method of re-
cruitment employed in the current study. To be included
in the study, participants had to be over 18 years of age
and have proficient English language skills. Participation
was restricted to those who had received therapy previ-
ously, and excluded those currently receiving therapy.
Website respondents viewed an information and consent
form and interested viewers were invited to respond an-
onymously in a study asking ‘Have you had an interesting
experience in therapy?’- in essence a neutral invitation
avoiding the risk of limiting respondents to only those
who had experienced a negative therapy. Participants were
asked to indicate what type of therapy they had received
and were given access to therapy descriptions. Participants
were also asked for relevant information regarding their
therapy experience (length of therapy, session number,
session frequency, problem under treatment) and demo-
graphic information including age, sex and if on medica-
tion for the problem targeted in therapy’.
Measures
Participants were required to complete all measures on
two occasions (two weeks apart) as the broader study
was designed to assess test re-test reliability [9]. Partici-
pants were emailed the measures two weeks following
the initial completion, and sent one reminder to maxi-
mise completion response rate at time two.
The ETQ is a 63-item scale. Participants are asked to
rate statements on a 5-point Likert scale (ranging from
strongly disagree (1), strongly agree (5)) assessing how
each statement reflects their therapeutic experience. The
five factors of the ETQ have been found to demonstrate
good internal consistency (.67-.96) and high test-retest
reliability (0.76-0.96) [9]. Scale scores are derived by
summing raw scores of each individual item that loads
on that scale, including reverse scoring for negative loaded
items. Twenty one items load on ‘Negative Therapist’
scale, 13 items on the ‘Preoccupying Therapy’ scale, 12
items on the ‘Beneficial Therapy’ scale, 6 items on the
‘Idealization of Therapist’ scale and 11 items on the
‘Passive Therapist’ scale. A higher mean score indicates
a higher degree of endorsement for that scale (i.e. higher
mean score for ‘Negative Therapist’ indicates a negative
impression of the therapist).
The TSS is a measure of therapeutic alliance and
should, theoretically, be related to subscales of the ETQ.
The TSS measures therapist characteristics that contrib-
ute to patient satisfaction. It is a 47-item scale, rated on
a 4-point Likert scale (very true (1), very untrue (4)), and
derives 5 scales of: care-concern, directive-control,
critical-confronting, communication and charisma. All
scales have been shown to have high internal reliability
(.79-.96) [10]. Scale scores are derived by summing raw
scores of each individual items that loads on that scale,
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items load on the ‘Care-Concern’ scale, 9 items on the
‘Directive-Control’ scale, 11 items on the ‘Communica-
tion’ scale, 8 items on the ‘Charisma’ scale and 9 items
on the ‘Critical-Confronting’ scale. A higher mean
score indicates a higher degree of endorsement for that
scale (i.e. a higher mean score for ‘Care-Concern’ indi-
cates the therapist was perceieved as empathic and un-
derstanding by the patient).
The Quick Inventory of Depressive Symptoms- Self
Rated (QIDS-SR) is a 16-item scale measuring severity
of depression over the past week. Participants are
asked to select which item best reflects how they have
been feeling over the past seven days on a 4-point
Likert-scale. The measure has been found to have high
internal consistency (.86) [11] and high construct val-
idity [12].
Hypotheses testing
Correlational analyses were undertaken to examine
associations between ETQ and TSS scale scores to
determine construct validity, both before and after
controlling for depression severity by use of the QIDs-
SR. As the TSS ‘Critical Confronting’ scale relates to a
judgemental therapist, but also one who increases ten-
sion during therapy and is similar to the ETQ ‘Negative
Therapist’ scale, we anticipated that these two scales
would have a strong positive association. The TSS
‘Care and Concern’ scale captures empathy and under-
standing, and the TSS ‘Communication’ scale captures
open and realistic interactions - both of which are key
ingredients of successful therapy and we therefore pre-
dicted these scales would highly correlate with the
ETQ ‘Beneficial Therapy’ scale. The TSS ‘Charisma’
scale captures the extent to which the patient finds the
therapist special and unique, and conceptually links
with the ETQ ‘Idealisation of Therapist’ scale, so that
we predicted these scales to be highly correlated. The
TSS ‘Directive Control’ scale relates to the therapist
exerting direct influence or providing specific guidance
to the patient and would be expected to have a high
inverse association to the ETQ ‘Passive Therapist’ scale.
The ETQ ‘Preoccupying Therapy’ scale was not antici-
pated to be associated with any of the TSS scales and was
examined in an exploratory manner.
As depression severity might artefactually influence a
patient’s ratings of their therapist and therapeutic ex-
perience, current depression severity was quantified by
the QIDs-SR. It was expected that depression severity
would have a moderate, positive correlation with the
ETQ ‘Negative Therapist’ and ‘Passive Therapist’ scales.
It was also expected that depression severity would have
a moderate, inverse association with the ETQ ‘Beneficial
Therapy’ scale.Results
Of the 106 participants completing the first adminis-
tration of the questionnaires, 46 completed the sec-
ond administration with an average interval of 19 days
(SD = 7.1 days). The 46 participants were older than the
106 (t = −2.3, p = 0.02) and were less likely to be taking
medication for their problem while receiving therapy
(χ2 = 4.0 p = 0.04), however they did not differ in length
of therapy (χ2 = 5.2), total number of sessions (t = −1.0),
frequency of therapy (χ2 = 4.7), gender (χ2 = 0.17), problem
under treatment (χ2 = 5.3), or type of therapy (χ2 = 4.4) (all
p > 0.05). These 46 comprise our study sample, and their
characteristics are provided in Table 1.
Table 2 reports the means and standard deviations of
the ETQ and TSS scales. Table 3 reports Pearson correl-
ation analyses of the ETQ and TSS measures. As both
measures were administered at two differing time-
points, correlations for both time-points are reported.
Significant correlations were quantified between the
relevant ETQ and TSS scales as hypothesised. Correlations
were interpreted using Dancey and Reidy’s categorisation
where ±1 indicates a perfect correlation; ±0.7 - ±0.9 indi-
cates a strong or high correlation; ±0.4 - ±0.6 indicates a
moderate correlation; ±0.1 - ±0.3 indicates a low or weak
correlation and 0 indicates no correlation [13]. Partial
correlations were used in order to control for depres-
sion severity, and no associations differed in significance
or strength when controlling for depression severity.
Discussion
Establishing the validity of a new scale is fundamental to
its use. This study was designed to determine whether the
validity of the ETQ could be supported, with encouraging
findings. The ETQ ‘Negative Therapist’ scale was highly
correlated with the TSS ‘Critical Confronting’ scale, with
such correlations observed at both administration time-
points so indicating stability. Similar results were observed
for associations between the ETQ ‘Beneficial Therapy’ and
the TSS ‘Care and Concern’ and ‘Communication’ scales.
The ETQ ‘Idealisation of Therapist’ scale was expected to
be associated with the TSS ‘Charisma’ scale, but the correl-
ation was only moderate. It appears that while the TSS
‘Charisma’ scale and the ETQ ‘Idealisation of Therapist’
scale have come conceptual overlap, the ETQ ‘Idealisation
of Therapist’ scale may reflect more inherent negativity
(e.g. “I didn’t feel like I was capable of making decisions
without first consulting my therapist”), in contrast to
the more positive characteristics implied by the TSS
‘Charisma’ scale (my therapist “Was the sort of person
people would look up to and respect”). Nonetheless, the
association was stable over time. It was anticipated that
the final ‘Passive Therapist’ scale would be negatively
associated with the TSS ‘Directive Control’ scale. While
the negative correlations were stable, the association
Table 1 Sample Characteristics n = 46
Gender: Male 5 (10.9%)
Female 41 (89.1%)
Therapist: Psychologist 28 (60.9%)
Psychiatrist 11 (23.9%)
Counsellor 3 (6.5%)
Social Worker 2 (4.3%)
GP 2 (4.3%)
Therapy: General Counselling 12 (26.1%)
CBT 18 (39.1%)
IPT 4 (8.7%)
Psychodynamic Psychotherapy 6 (13.0%)
Long-term psychotherapy 6 (13.0%)




Eating Disorder 3 (6.5%)
Other 6 (13.0%)
Frequency of therapy < Once per month 3 (6.5%)
Once per month 10 (21.7%)
Once every 3 weeks 5 (10.9%)
Once per fortnight 11 (23.9%)
Once per week 14 (30.4%)
Twice a week 1 (2.2%)
> Twice per week 2 (4.3%)
Duration of therapy < One month 1 (2.2%)
Two-three months 9 (19.6%)
Four to six months 7 (15.2%)
Six to twelve months 5 (10.9%)
One to two years 10 (21.7%)
More than 2 years 14 (30.4%)
Medication Yes 26 (56.5%)
No 20 (43.5%)




Table 2 Means of ETQ and TSS Subscales (n = 46)
Measure Subscale Mean (SD)
ETQ scales: Negative Therapist 44.09 (20.6)
Preoccupying Therapy 36.96 (9.7)
Beneficial Therapy 39.65 (13.3)
Idealisation of Therapist 12.33 (3.6)
Passive Therapist 27.9 (10.2)
TSS scales Critical Confronting 15.78 (6.5)
Care and Concern 29.48 (8.1)
Charisma 17.26 (4.3)
Communication 34.28 (6.0)
Directive Control 25.54 (4.8)
The ETQ and TSS scale scores are derived by the summing of raw scores of
the individual items that load on that construct, including reverse scoring for
negative loaded items. A higher mean score indicates a higher degree of
endorsement for that scale.
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items covered under ‘Passive Therapist’.
Correlational analyses involving the ETQ ‘Preoccupying
Therapy’ scale showed it to be significantly positively cor-
related with the TSS ‘Critical Confronting’ scale and nega-
tively correlated with the ‘Directive Control’, ‘Care and
Concern’ and ‘Communication’ TSS scales. The positive
association with the TSS ‘Critical Confronting’ scale(which includes items such as the therapist was ‘critical
of me’) reflects how therapy with a practitioner who
seems to do nothing but criticise could lead to rumin-
ation - as seen in ‘Preoccupying Therapy’ items such as
‘with therapy I am aware of having more problems
than before therapy’. Similarly, therapy that is low on
‘Care and Concern’ and ‘Communication’ would also
become preoccupying as the patient is likely to feel
invalidated and unheard by their therapist. The negative
association with ‘Directive Control’ appears to imply that
without some direction to the therapy it can become pre-
occupying, and possible stagnant.
It was surprising that depression severity did not affect
the significance or strength of any of the observed asso-
ciations between the ETQ and TSS. This may reflect the
robustness of these domains of therapeutic outcomes re-
gardless of disorder severity, and possibly disorder type.
Having a reliable and valid measure of psychotherapy
‘side-effects’ has potential advantages, most clearly in
studies evaluating comparative therapies but where
findings may well be distinctly influenced by therapy
not just therapist factors. In the development paper,
participants were asked if they left therapy for reasons
other than their problem improving. One-quarter reported
they left as their problem was not improving, 17% indicated
that they were dissatisfied with their therapist or the ther-
apy and 8% stated that their therapy was actually making
them worse [9]. It is unlikely that these patients would
ever have discussed their therapy termination with their
practitioner especially if they felt the therapy was making
them worse. In such cases the ETQ could be a useful
mechanism for uncovering termination reasons which
might otherwise have gone undisclosed. We therefore
consider that the ETQ could be utilized in research to
help distinguish unhelpful, or beneficial, aspects of differ-
ent therapy modalities. For the ETQ to be considered
Table 3 Correlational analyses examining a priori associations between ETQ and TSS scales with partial correlations
controlling for depression severity using the QIDS (n = 46)
ETQ scales TSS scales Time point Correlation Partial correlation
‘Negative Therapist’ ‘Critical Confronting’ 1 0.77** 0.79**
2 0.82** 0.81**
‘Preoccupying Therapy’ ‘Critical Confronting’ 1 0.53** 0.54**
2 0.57** 0.53**
‘Care and Concern’ 1 −0.51** −0.48**
2 −0.54** −0.55**
‘Charisma’ 1 −0.26 −0.24
2 −0.26 −0.34*
‘Communication’ 1 −0.50** −0.46*
2 −0.47** −0.48**
‘Directive Control’ 1 −0.48** −0.46*
2 −0.52** −0.46*
‘Beneficial Therapy’ ‘Care Concern’ 1 0.78** 0.80**
2 0.78** 0.78**
‘Beneficial Therapy’ ‘Communication’ 1 0.73** 0.73**
2 0.74** 0.72**
‘Idealisation of Therapist’ ‘Charisma’ 1 0.57** 0.59**
2 0.49** 0.50**
‘Passive Therapist’ ‘Directive Control’ 1 −0.46** −0.46*
2 −0.54** −0.54**
**Significant p ≤ 0.001, *Significant P < 0.05.
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would also need to demonstrate the ability to detect clin-
ically important change over time [14]. External respon-
siveness, the extent to which changes in a measure over
time relate to changes in a reference measure of health
[15], could be assessed in future studies by comparing re-
sponses on the ETQ to an overall measure of mental
health status.
Study results further quantify the psychometric
properties of the ETQ, establishing the measure as a
valid indicator of psychotherapy ‘side-effects’. Our
findings also raise a semantic issue. The ETQ has a
premise of quantifying ‘side-effects’ while the TSS seeks to
measure ‘treatment alliance’, the latter being a softer and
less provocative construct, though in reality the two do-
mains have considerable overlap. Failure to establish a
treatment alliance can reflect a range of factors brought
by the patient, the therapist or both, and which do not
ascribe ‘cause’ or ‘blame’ to the therapist of necessity.
The use of ‘side-effects’ is a more active descriptor that
implicates the therapist or therapy more directly, albeit
effectively impugning no contribution by the patient to
the process. Each has their own connotations and each
variably risks being too lenient or too condemnatory in
their tone and positioning. In addition, there is considerableoverlap between certain scales of the ETQ and TSS as
demonstrated by the large associations found in this
paper. We note that despite the semantic difference
between ‘therapeutic alliance’ and ‘side-effects’, it may
be redundant to administer both instruments in their
entirety in all research circumstances. Progress may be
assisted by studies that use both measures in, addition
to qualitative information, to determine which of these
measures may be most useful in different circumstances.
This study does have limitations. Results were derived
from a small sample and it is possible that more reminders
may have increased completion of the measures at the
second time point. We also did not collect information
such as time since the therapy ceased, gender of the
therapist or the type of medication participants used.
The sample obtained via the internet was likely to over-
represent patients being treated for mood disorders due
to recruitment through the Black Dog Institute website
and was also skewed towards females and those receiving
long-term therapy. It is therefore possible that females
and those seeking longer term therapy were more likely to
actively seek information from the Black Dog website
and be exposed to research recruitment invitations. In
addition, no pilot testing or cognitive assessments were
completed with participants to assess understanding of
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pants who ‘have had an interesting or unusual experience
of therapy,’ we may have attracted individuals who have
had extreme or unusual experiences of psychotherapy
(both positive and negative). As such the generalisability
of these findings should be taken with some caution but,
as our main objective was a validation study, such limita-
tions might be expected to have had minimal impact on
those analyses.
Conclusions
This study supports the validity of the ETQ as a measure
of negative ingredients or side-effects in psychotherapy.
The ETQ can be used to determine potential causes of
therapy failure, and as such may be of particular use in
treatment efficacy studies, and might be used alone or to
complement measures of therapeutic alliance.
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